Canada: Persistent hypoxemia requiring short-term oxygen therapy (STOT) following an acute respiratory illness in COPD is a marker of disease progression to long-term oxygen therapy (LTOT), states a.
get an as ma attack. that s what we re seeing in the patients. who not only have active air way disease like asthma. some are younger who have smaller air ways than adults. and what maybe a bronchitis for you or me can really set up difficulty breathing. for medical treatment for young kids. even without diagnosed as ma. we re seeing on top of the normal winter surge of pediatric admissions ask it s normal to see a rise in hospitalization because of flu and respiratory virus. and the standard viruss. we re seeing kids getting the same exacerbations of the diseases. caused by covid. what i m thankful we re not seeing a tremendous amount of is pneumonia. being caused by the virus in those kids. new york mayor is planning to keep schools open. l.a. school district is ordering mandatory negative tests for
predict. experts. yes, there will be another pandemic. it is something we know from epidemiological data. and we ve got to be more prepared. when we talk about preparedness, we need to think about preparedness in mental health and behavioral health. we need to think about things like mental health first aid or emotional first aid. we hear a lot about how we recognize warning signs for stroke or the warning signs of a heart attack but they have to understand, how do you recognize when a person is going through toxic stress or they re in crisis and how do you refer people to resources that can help them mitigate these dangerous and very concerning times and what do we do? what supports and connectivity do we build into our normal and daily practice to help people head off, i would say, exacerbations in mood disorders. dr. pernell, thank you. thanks, jake. coming up, a race to watch for the u.s. house of representatives. the challenger to congressman matt gaetz who is raising eyeb
Enrollment in a high-deductible health plan (HDHP) is not linked to changes in asthma medication use or asthma exacerbations when medications are exempt from the deductible.
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) and AstraZeneca Thursday said results from the Phase 3 study of tezepelumab in severe asthma patients, dubbed Navigator, have been published in the New England